[go: up one dir, main page]

UA97663C2 - Применение bifidobacterium lactis cncm i-3446 для улучшения кишечной микробиоты у детей, родившихся путем кесарева сечения - Google Patents

Применение bifidobacterium lactis cncm i-3446 для улучшения кишечной микробиоты у детей, родившихся путем кесарева сечения

Info

Publication number
UA97663C2
UA97663C2 UAA200910897A UAA200910897A UA97663C2 UA 97663 C2 UA97663 C2 UA 97663C2 UA A200910897 A UAA200910897 A UA A200910897A UA A200910897 A UAA200910897 A UA A200910897A UA 97663 C2 UA97663 C2 UA 97663C2
Authority
UA
Ukraine
Prior art keywords
promoting
development
bifidobacterium lactis
intestinal microbiota
caesarean section
Prior art date
Application number
UAA200910897A
Other languages
English (en)
Ukrainian (uk)
Inventor
Карл-Йозеф Хубер-Хааг
Мари-Клер Фишот
Флоренс Рошат
Норберт Спренгер
Original Assignee
Нестек С.А.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Нестек С.А. filed Critical Нестек С.А.
Publication of UA97663C2 publication Critical patent/UA97663C2/ru

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/741—Probiotics
    • A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
    • A61K35/747—Lactobacilli, e.g. L. acidophilus or L. brevis
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/135—Bacteria or derivatives thereof, e.g. probiotics
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/40—Complete food formulations for specific consumer groups or specific purposes, e.g. infant formula
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/741—Probiotics
    • A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
    • A61K35/745—Bifidobacteria
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/12—Antidiarrhoeals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/14—Prodigestives, e.g. acids, enzymes, appetite stimulants, antidyspeptics, tonics, antiflatulents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2400/00—Lactic or propionic acid bacteria
    • A23V2400/11—Lactobacillus
    • A23V2400/175—Rhamnosus
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2400/00—Lactic or propionic acid bacteria
    • A23V2400/51—Bifidobacterium
    • A23V2400/531—Lactis

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Mycology (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Microbiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nutrition Science (AREA)
  • Epidemiology (AREA)
  • Immunology (AREA)
  • Polymers & Plastics (AREA)
  • Food Science & Technology (AREA)
  • Molecular Biology (AREA)
  • Pediatric Medicine (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Pulmonology (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)

Abstract

Применение Bifidobacterium lactis CNCM I-3446 в производстве лекарственного средства или лекарственной пищевой композиции в качестве стимулятора развития начальной бифидогенной кишечной микробиоты или в качестве средства для снижения риска дальнейшего развития аллергии, или в качестве средства для предупреждения или лечения диареи у детей, родившихся путем кесарева сечения. Дополнительно может содержать смесь олигосахаридов.
UAA200910897A 2007-03-28 2008-03-27 Применение bifidobacterium lactis cncm i-3446 для улучшения кишечной микробиоты у детей, родившихся путем кесарева сечения UA97663C2 (ru)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP07105074A EP1974743A1 (en) 2007-03-28 2007-03-28 Probiotics to Improve Gut Microbiota
PCT/EP2008/053611 WO2008116892A1 (en) 2007-03-28 2008-03-27 Probiotics to improve gut microbiota

Publications (1)

Publication Number Publication Date
UA97663C2 true UA97663C2 (ru) 2012-03-12

Family

ID=38051788

Family Applications (2)

Application Number Title Priority Date Filing Date
UAA200910897A UA97663C2 (ru) 2007-03-28 2008-03-27 Применение bifidobacterium lactis cncm i-3446 для улучшения кишечной микробиоты у детей, родившихся путем кесарева сечения
UAA200910896A UA97662C2 (ru) 2007-03-28 2008-03-27 Применение синбиотика для улучшения кишечной микробиоты у детей, родившихся путем кесаревого сечения

Family Applications After (1)

Application Number Title Priority Date Filing Date
UAA200910896A UA97662C2 (ru) 2007-03-28 2008-03-27 Применение синбиотика для улучшения кишечной микробиоты у детей, родившихся путем кесаревого сечения

Country Status (15)

Country Link
US (4) US20100086527A1 (ru)
EP (6) EP1974743A1 (ru)
CN (4) CN101652079A (ru)
AU (4) AU2008231775A1 (ru)
BR (4) BRPI0809355A2 (ru)
CA (4) CA2679081A1 (ru)
ES (2) ES2434566T3 (ru)
MX (4) MX337667B (ru)
MY (1) MY151137A (ru)
PL (2) PL2131680T3 (ru)
PT (2) PT2131859T (ru)
RU (4) RU2009139660A (ru)
UA (2) UA97663C2 (ru)
WO (4) WO2008116892A1 (ru)
ZA (3) ZA200907731B (ru)

Families Citing this family (51)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AUPQ899700A0 (en) 2000-07-25 2000-08-17 Borody, Thomas Julius Probiotic recolonisation therapy
ES2553636T3 (es) * 2006-03-07 2015-12-10 Nestec S.A. Mezcla simbiótica
BRPI0712844A2 (pt) * 2006-06-13 2012-07-31 Nestec Sa prevenÇço e tratamento da otite mÉdia com cepas bacterianas nço patogÊnicas.
EP2147678A1 (en) * 2008-07-21 2010-01-27 Nestec S.A. Probiotics to increase IgA secretion in infants born by caesarean section
US8498729B2 (en) 2008-08-29 2013-07-30 Smp Logic Systems Llc Manufacturing execution system for use in manufacturing baby formula
RU2509478C2 (ru) * 2008-12-05 2014-03-20 Нестек С.А. Пробиотическая композиция, предназначенная для младенцев с низкой массой тела при рождении
EP2206506A1 (en) * 2008-12-18 2010-07-14 Bracco Imaging S.p.A Probiotic formulations
WO2010103132A1 (es) * 2009-03-10 2010-09-16 Hero España, S.A. Aislamiento, identificación y caracterización de cepas con actividad probiótica a partir de heces de lactantes alimentados exclusivamente con leche materna
SG177541A1 (en) * 2009-07-31 2012-02-28 Nestec Sa Nutritional composition for breast-fed infants or pets with probiotics and selected nutrients
EP2289527B1 (en) 2009-08-25 2018-02-21 Nestec S.A. Bifidobacterium longum and functional GI disorders
WO2011151941A1 (ja) 2010-06-04 2011-12-08 国立大学法人東京大学 制御性ｔ細胞の増殖または集積を誘導する作用を有する組成物
EP2452575A1 (en) * 2010-11-15 2012-05-16 Nestec S.A. Array of age-tailored nutritional formula with probiotics
EP2465507A1 (en) * 2010-11-23 2012-06-20 Nestec S.A. Oligosaccharide composition for treating skin diseases
EP2455387A1 (en) 2010-11-23 2012-05-23 Nestec S.A. Oligosaccharide mixture and food product comprising this mixture, especially infant formula
WO2012089782A1 (en) * 2010-12-29 2012-07-05 Nestec S.A. Fiber and probiotics for reducing intestinal symptoms related to stress
EE05750B1 (et) 2011-02-25 2015-06-15 OÜ Tervisliku Piima Biotehnoloogiate Arenduskeskus Isoleeritud mikroorganismi tüvi Lactobacillus gasseri MCC2 DSM 23882 ning selle kasutamine
EP2510932A1 (en) * 2011-04-15 2012-10-17 Nestec S.A. Lactobacillus paracasei NCC2461 (ST11) for use by perinatal maternal administration in the reduction and prevention of allergies in progeny
WO2012177556A2 (en) 2011-06-20 2012-12-27 H.J. Heinz Company Probiotic compositions and methods
US9463169B2 (en) 2011-08-17 2016-10-11 Microbiome Therapeutics, Llc Human gastrointestinal microbiome modulating food supplement for improving blood glucose regulation
MX354727B (es) * 2011-10-18 2018-03-16 Nestec Sa Composicion para uso en la promocion de absorcion de magnesio y/o retencion de magnesio.
EP3569690B1 (en) 2011-12-01 2024-08-28 The University of Tokyo Human-derived bacteria that induce proliferation or accumulation of regulatory t cells
JP6115094B2 (ja) * 2012-11-15 2017-04-19 株式会社Ｇｓユアサ 蓄電素子及び蓄電素子の製造方法
PT3470074T (pt) 2013-05-10 2020-11-30 Heinz Co Brands H J Llc Probióticos
MX379145B (es) * 2013-11-15 2025-03-11 Soc Des Produits Nestle S A Star Ficomposiciones para prevenir o tratar alergias en infantes a partir de o alimentados por madres no secretoras mediante el suministro de oligosacaridos fucosilados, particularmente entre los niños en riesgo o nacidos por cesárea.
MX2016006221A (es) 2013-11-15 2016-08-08 Nestec Sa Composiciones para usar en la prevencion o tratamiento de la enterocolitis necrotizante en infantes y niños pequeños.
MX2016006220A (es) * 2013-11-15 2016-08-08 Nestec Sa Composiciones para usar en la prevencion o tratamiento de la enterocolitis necrotizante en infantes y niños pequeños nacidos por cesarea.
MX2016006060A (es) * 2013-11-15 2016-08-03 Nestec Sa Composiciones para usar en la prevencion o tratamiento de la enterocolitis necrotizante en infantes y niños pequeños.
CN106659226A (zh) 2014-08-18 2017-05-10 雀巢产品技术援助有限公司 用于降低以后生命中肥胖风险的益生元
CN106794207A (zh) * 2014-10-29 2017-05-31 雀巢产品技术援助有限公司 使用罗伊氏乳杆菌在生命早期恢复微生物群生态失调
EP3294308A4 (en) * 2015-05-14 2019-03-06 University of Puerto Rico PROCESS FOR RECOVERING THE BIOZOOSE OF NEWBORN
AU2016303003A1 (en) * 2015-08-04 2017-12-07 Société des Produits Nestlé S.A. Nutritional compositions and infant formulas comprising Bifidobacterium animalis ssp. lactis and optionally a mix of oligosaccharides for inducing a gut microbiota close to the one of breast fed infants
WO2017043963A1 (en) * 2015-09-11 2017-03-16 N.V. Nutricia Kit of parts for stimulating microbiota health after non-natural birth
WO2017117142A1 (en) 2015-12-28 2017-07-06 New York University Device and method of restoring microbiota of newborns
WO2017129644A1 (en) 2016-01-26 2017-08-03 Nestec S.A. Compositions with specific oligosaccharides to prevent or treat allergies
JP6853821B2 (ja) * 2016-05-31 2021-03-31 森永乳業株式会社 脳機能改善剤
US20180030403A1 (en) 2016-07-28 2018-02-01 Bobban Subhadra Devices, systems and methods for the production of humanized gut commensal microbiota
RU2748279C2 (ru) * 2016-08-04 2021-05-21 Сосьете Де Продюи Нестле С.А. Питательные композиции и детские смеси, содержащие смесь олигосахаридов и необязательно bifidobacterium lactis для профилактики, лечения или снижения степени тяжести диареи, не связанной с ротавирусом
WO2018202657A1 (en) * 2017-05-05 2018-11-08 Nestec S.A. Treatment of infant colic
WO2019025637A1 (en) * 2017-08-04 2019-02-07 Nestec S.A. PRECONDITIONED PROBIOTIC BACTERIA IN A GOS-CONTAINING ENVIRONMENT AND USE THEREOF
EP3801557A4 (en) * 2018-05-30 2022-03-09 Evolve Biosystems Inc. COMPOSITIONS AND METHOD OF USE FOR BIFIDOBACTERIUM LONGUM SUBSP. COMPETENT FOR H5
CN108935698A (zh) * 2018-09-11 2018-12-07 内蒙古伊利实业集团股份有限公司 一种预防小儿腹泻疾病的营养组合物及应用
CN109497271A (zh) * 2018-12-06 2019-03-22 江苏奥迈生物科技有限公司 一种提高断奶仔猪免疫力的复合饲料添加剂及其制备方法
US20220293275A1 (en) * 2019-06-11 2022-09-15 CJ Bioscience. Inc Method for detecting gut dysbiosis of infant
TWI754302B (zh) * 2019-06-21 2022-02-01 大江生醫股份有限公司 乳雙歧桿菌tci604及其代謝產物的應用
CN111053244A (zh) * 2019-12-06 2020-04-24 山东体育学院 一种基于肠道微生物的营养调节方法及系统
CN111296711A (zh) * 2020-03-31 2020-06-19 广州纽缤乐营养科技股份有限公司 一种益生菌固体饮料及其制备方法
EP4180880A1 (fr) * 2021-11-10 2023-05-17 Montres Breguet S.A. Dispositif d'affichage d'une succession d'indications d'une grandeur temporelle pour une pièce d'horlogerie
JP2025521180A (ja) * 2022-06-10 2025-07-08 ディーエスエム アイピー アセッツ ビー．ブイ． ビタミンＢ２及びラクトバチルス・ラムノサス（Ｌａｃｔｏｂａｃｉｌｌｕｓ ｒｈａｍｎｏｓｕｓ）を含む組み合わせ
WO2023237687A1 (en) * 2022-06-10 2023-12-14 Dsm Ip Assets B.V. Combinations comprising vitamin b2 and lactobacillus rhamnosus
KR20250117389A (ko) 2022-11-17 2025-08-04 엥스티튀 나쇼날 드 르쉐르슈 푸흐 라그리컬튀흐, 랄리망따씨옹 에 랑비허른망 리모실락토바실루스 무코사에 및 glp-1 증가가 필요한 장애
WO2024160209A1 (zh) * 2023-02-01 2024-08-08 北京三元食品股份有限公司 一株母乳来源的鼠李糖乳酪杆菌及应用

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4839281A (en) 1985-04-17 1989-06-13 New England Medical Center Hospitals, Inc. Lactobacillus strains and methods of selection
SU1743607A1 (ru) * 1990-02-05 1992-06-30 2-й Московский государственный медицинский институт им.Н.И.Пирогова Способ профилактики дисбактериоза кишечника у новорожденных детей
DK0768375T4 (da) 1992-07-06 2002-09-16 Nestle Sa Mælkesyrebakterier
EP0577903B1 (fr) 1992-07-06 1997-12-17 Societe Des Produits Nestle S.A. Agent antigastrite
FI104465B (fi) 1995-06-14 2000-02-15 Valio Oy Proteiinihydrolysaatteja allergioiden hoitamiseksi tai estämiseksi, niiden valmistus ja käyttö
NL1010770C2 (nl) * 1998-12-09 2000-06-13 Nutricia Nv Preparaat dat oligosacchariden en probiotica bevat.
EP1034787A1 (en) 1999-03-11 2000-09-13 Société des Produits Nestlé S.A. Lactobacillus strains preventing diarrhea caused by pathogenic bacteria
DE19958985A1 (de) * 1999-12-07 2001-06-13 Nutricia Nv Oligosaccharidmischung
FI110668B (fi) * 2000-06-20 2003-03-14 Aboatech Ab Oy Probioottien käyttö atooppisten sairauksien primaariseen ehkäisyyn
WO2005000748A1 (en) 2003-06-27 2005-01-06 Bio-Circuit Aps A biogas producing facility with anaerobic hydrolysis
EP2108269A1 (en) * 2005-04-13 2009-10-14 Nestec S.A. Infant formula with low dose probiotics and low dose proteins
EP1776877A1 (en) * 2005-10-21 2007-04-25 N.V. Nutricia Method for stimulating the intestinal flora
RU2430631C2 (ru) 2006-02-10 2011-10-10 Нестек С.А. Пребиотическая смесь олигосахаридов и пищевой продукт, ее содержащий
ES2553636T3 (es) * 2006-03-07 2015-12-10 Nestec S.A. Mezcla simbiótica
BRPI0712844A2 (pt) * 2006-06-13 2012-07-31 Nestec Sa prevenÇço e tratamento da otite mÉdia com cepas bacterianas nço patogÊnicas.

Also Published As

Publication number Publication date
ES2434566T3 (es) 2013-12-16
ZA200907541B (en) 2011-04-28
AU2008231778A1 (en) 2008-10-02
MX2009009442A (es) 2009-09-14
MX2009009318A (es) 2009-09-10
MX337667B (es) 2016-03-14
RU2009139667A (ru) 2011-05-10
CA2679081A1 (en) 2008-10-02
WO2008116907A1 (en) 2008-10-02
EP2131859B1 (en) 2016-04-27
CA2680093A1 (en) 2008-10-02
ES2577434T3 (es) 2016-07-14
WO2008116904A1 (en) 2008-10-02
MX2009010252A (es) 2009-10-13
CN101646453A (zh) 2010-02-10
RU2009139669A (ru) 2011-05-10
AU2008231775A1 (en) 2008-10-02
US20100119497A1 (en) 2010-05-13
RU2456008C2 (ru) 2012-07-20
PT2131859T (pt) 2016-07-13
AU2008231702A1 (en) 2008-10-02
AU2008231763B2 (en) 2013-10-31
US20100086527A1 (en) 2010-04-08
EP2131859A1 (en) 2009-12-16
MX2009009931A (es) 2009-09-24
EP1974743A1 (en) 2008-10-01
RU2009139660A (ru) 2011-05-10
EP2131680A1 (en) 2009-12-16
CN101646452A (zh) 2010-02-10
RU2521500C2 (ru) 2014-06-27
EP2489280A2 (en) 2012-08-22
US20100150874A1 (en) 2010-06-17
EP2489280A3 (en) 2013-06-26
BRPI0809355A2 (pt) 2014-09-02
WO2008116916A1 (en) 2008-10-02
UA97662C2 (ru) 2012-03-12
BRPI0809626A2 (pt) 2014-09-23
EP2131680B1 (en) 2013-08-14
AU2008231763A1 (en) 2008-10-02
MY151137A (en) 2014-04-30
RU2009139658A (ru) 2011-05-10
US20100119488A1 (en) 2010-05-13
CA2682654A1 (en) 2008-10-02
ZA200907731B (en) 2011-04-28
WO2008116892A1 (en) 2008-10-02
EP2129242A1 (en) 2009-12-09
EP2129393A1 (en) 2009-12-09
BRPI0809356A2 (pt) 2014-09-02
CN101652080A (zh) 2010-02-17
ZA200907538B (en) 2011-04-28
PL2131680T3 (pl) 2014-01-31
CA2678994A1 (en) 2008-03-27
CN101652079A (zh) 2010-02-17
PT2131680E (pt) 2013-10-28
AU2008231702B2 (en) 2014-01-16
PL2131859T3 (pl) 2016-12-30
BRPI0809622A2 (pt) 2014-09-16

Similar Documents

Publication Publication Date Title
UA97663C2 (ru) Применение bifidobacterium lactis cncm i-3446 для улучшения кишечной микробиоты у детей, родившихся путем кесарева сечения
MY158816A (en) Probiotics for reduction of risk of obesity
MY159072A (en) Probiotics to increase iga secretion in infants born by caesarean section
MY150657A (en) Reduction of risk of diarrhoea
PH12014501749B1 (en) A nutritional composition comprising probiotics and improving sleep patterns
UA100551C2 (en) Synbiotic mixture
MY159076A (en) Use of oligosaccharides containing n-acetyllactosamine for maturation of immune responses in neonates
MY196432A (en) Methods Of Using Human Milk Oligosaccharides For Improving Airway Respiratory Health
UA100985C2 (ru) Композиция для питания с нежизнеспособной бифидобактерией и неусваиваемым олигосахаридом
NZ601141A (en) Nutritional formulas containing synbiotics
MY169326A (en) Human milk oligosaccharides for preventing injury and/or promoting healing of the gastrointestinal tract
PH12013501291A1 (en) Synbiotic combination of probiotic and human milk oligosaccharides to promote growth of beneficial microbiota
MX2012005524A (es) Cepa de probioticos bifidobacterium.
MY191538A (en) Human milk oligosaccharides to promote growth of beneficial bacteria
JP2009539371A5 (ru)
PH12017502182A1 (en) Nutritional compositions and infant formulas comprising bifidobacterium animalis ssp. lactis and optionally a mix of oligosaccharides for inducing a gut microbiota close to the one of breast fed infants
IN2012DN06309A (ru)
WO2009080800A3 (en) Method for decreasing abdominal girth by administering a bifidobacterium bacteria
PH12014500185A1 (en) Galactooligosaccharides for preventing injury and/or promoting healing of the gastrointestinal tract
TH117336A (th) โพรไบโอติกสำหรับลดความเสี่ยงต่อโรคอ้วน
TH144912A (th) การลดความเสี่ยงในการเป็นโรคท้องเสีย
UA52520U (ru) Способ лечения нарушений функционального состояния кишечника у новорожденных и детей младенческого возраста
AU2008902737A0 (en) Soft Human Stomach Model for In Vitro Digestive Testing
PH12013501388A1 (en) Methods of using human milk oligosaccharides for improving airway respiratory health
UA36020U (ru) Способ электретизации измельченного субстрата лиофилизированной биологической ткани